Concepedia

Yipin Lu

YL

30

Publications

6.2K

Citations

24

H-Index

2003

Active since

Affiliations

Novartis (United States)(Current)

University of Michigan

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

University of California, Berkeley

Yipin Lu is an author at Novartis (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineDrug DiscoveryNatural SciencesBiochemistryPharmacologyMolecular DockingMedicinal ChemistryMolecular BiologyChemical BiologyMolecular Pharmacology

Publications per year

2003–2023

30

Publications

30

The PDBbind Database: Collection of Binding Affinities for Protein−Ligand Complexes with Known Three-Dimensional Structures

Renxiao Wang, Xueliang Fang, Yipin Lu et al. · Journal of Medicinal Chemistry · 2004 · 1.1K citations

The PDBbind Database: Methodologies and Updates

Renxiao Wang, Xueliang Fang, Yipin Lu et al. · Journal of Medicinal Chemistry · 2005 · 913 citations

Engineering, Pdbbind Database, Big Data Indexing +19

Comparative Evaluation of 11 Scoring Functions for Molecular Docking

Renxiao Wang, Yipin Lu, Shaomeng Wang · Journal of Medicinal Chemistry · 2003 · 846 citations

Observed Conformation, Biochemistry, Protein Folding +12

Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction

Ke Ding, Yipin Lu, Zaneta Nikolovska‐Coleska et al. · Journal of Medicinal Chemistry · 2006 · 681 citations · Full text

Combinatorial Chemistry, Mdm2-p53 Interaction, Chemoprevention Strategy +19

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Sanjeev Shangary, Dongguang Qin, Donna McEachern et al. · Proceedings of the National Academy of Sciences · 2008 · 650 citations · Full text

Rows per page

1–5 of 30